Groundbreaking Discovery Could Revolutionize Early Detection and Save Lives

Fecal Bacteria May Indicate Stomach Cancer Risk

the presence of two specific types of streptococcus bacteria in a person's feces may indicate a high risk for stomach cancer. This finding has the potential to revolutionize early detection of this deadly disease.

Professor Fang Jingyuan, leading the research team at the digestive medicine department of the hospital, has identified Streptococcus constellatus and Streptococcus anginosus as potential biomarkers for stomach cancer. This non-invasive method, analyzing fecal microbiota, could significantly improve screening for both stomach cancer and its precancerous conditions.

Stomach cancer is a major health concern globally, with high incidence and mortality rates. Chronic atrophic gastritis is a primary precancerous condition, making early detection crucial. However, current screening methods like gastroscopy are limited by technical challenges and economic costs, making them unsuitable for large-scale screening.

The research team is optimistic about the potential of their discovery. They are currently developing a test kit that can analyze fecal samples for the presence of the identified streptococcus bacteria. This test kit holds significant clinical value and could offer hope to countless patients in the future.

This discovery is a significant step forward in the fight against stomach cancer. By enabling early detection through a simple, non-invasive test, this research has the potential to save countless lives.